MedTrace Logo

RESILIENCE: Personalizing Cardiovascular Health

NCT04551872 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 598

Last updated 2024-04-24

No results posted yet for this study

Summary

Obesity is a rapidly growing epidemic that is associated with the development of cardiovascular disease (CVD). However, some individuals with obesity appear to be resistant to CVD, and other individuals demonstrate resilience to obesity and CVD risk factors. The investigator's overall objective is to understand factors contributing to the heterogeneity of CVD resistance and resilience among individuals with obesity at Duke.

Conditions

  • Obesity
  • Cardiovascular Risk Factor

Interventions

BEHAVIORAL

Digital weight loss intervention

Participants with obesity enter into a proven 6 month weight loss program that utilizes health coaching and goal-setting. It is a remote intervention that is delivered entirely over their phones. Participants will also receive a FitBit and electronic scale.

Sponsors & Collaborators

Principal Investigators

  • Neha Pagidipati, MD, MPH · Duke University

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-22
Primary Completion
2023-03-22
Completion
2024-03-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04551872 on ClinicalTrials.gov